Elekta: Interim report, May-January 2021/22
STOCKHOLM, Feb. 24, 2022 /PRNewswire/ -- The demand for Elekta's solutions continued to be strong in the third quarter, the fifth consecutive quarter with underlying order growth, resulting in Elekta's strongest order backlog ever. However, the global supply chain challenges remained, and revenue...
Elekta announces preliminary third quarter results
STOCKHOLM, Feb. 14, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) today published preliminary financial results for the third quarter 2021/22. The demand for Elekta's precision radiation medicine solutions continued to be strong in the quarter, driven byEurope and recovery in several emerging markets ...
Invitation to the presentation of Elekta's third quarter 2021/22
STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at10:00 a.m. CET on February 24. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day. The company's development will be...
Elekta increases customer focus with direct presence in Philippines
STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established an office inthe Philippines' capital, Manila, to offer new and existing customers superior service, education and training opportunities and faster access to the latest cancer care solutions. A dire...
Elekta to appoint Tobias Hägglöv as Chief Financial Officer
STOCKHOLM, Jan. 7, 2022 /PRNewswire/ -- Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck. Tobias Hägglöv has previously held the role of CFO at Recipharm as well as senior management posit...
Elekta's new sustainability-linked bond oversubscribed
STOCKHOLM, Dec. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has issuedSEK 1.5 billion senior unsecured sustainability-linked bonds under its Medium Term Note Program (MTN-Program). One of the bonds, in the amount of SEK 1,150 million, has a maturity of 5 years with a coupon ...
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with...
Elekta: Interim report, May-October 2021/22
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenu...
Invitation to the presentation of Elekta's second quarter 2021/22
STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company's development will b...
Award-winning abstracts confirm benefits of Elekta Unity in precision radiation therapy
CHICAGO, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of new award-winning abstracts supporting the many benefits of Elekta Unity in treating cancer patients using precision radiation therapy. The abstracts add to the growing body of data manifesting Elekta Un...
Elekta establishes a framework for sustainability-linked bonds
STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds under itsMedium Term Note Program (MTN-Program). Elekta is among the first companies inSweden to est...
Elekta receives initial investment grade rating from S&P Global Ratings
STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta and to the Group's senior unsecured notes, with stable outlook. S&P notes that Elekta's rating r...
Elekta acquires Turkish distributor to strengthen market position
STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. (Özyürek A.Ş.). The acquisition will improve Elekta's market access in the region and ...
Elekta Unity MR-Linac featured in 72 abstracts at European radiation oncology congress
MADRID, August 31, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac. The research described in the abstracts was conducted at 14 leading cancer centers worldwide, ref...
Elekta's Board announces establishment of philanthropic Elekta Foundation
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The Elekta Foundation's mission is an important part of Elekta's environmental, social, and governan...
Report from the Annual General Meeting 2021 in Elekta
STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A statement from the CEO and P...
Invitation to the presentation of Elekta's first quarter 2021/22
STOCKHOLM, Aug. 11, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2021/22 at10:00 a.m. CEST onAugust 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day. The company's development will be...
GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to contin...
Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac
Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Uni...
Notice to the Annual General Meeting of Elekta AB (publ)
STOCKHOLM, July 21, 2021 /PRNewswire/ -- The shareholders of Elekta AB (publ), reg. no 556170-4015 are hereby convened to the Annual General Meeting to be held on Wednesday25 August 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be conducted wit...
